Advertisements

Flunol (Fluconazole)

Quick links to important sections

Flunol (Fluconazole)

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Flunol (Fluconazole)

Flunol is a trade name for a medication whose active component is Fluconazole (INN, International Nonproprietary Name). It is a synthetic compound specifically designed for systemic use.


Quick Facts

Property Description
Active Ingredient Fluconazole
Pharmacological Class Antifungal Agent (Triazole)
Primary Forms Capsule, Tablet, Oral Suspension, Intravenous Solution
Routes of Administration Oral, Intravenous
Origin Synthetic Compound

Identity and Classification of Fluconazole

Fluconazole is classified as a triazole antifungal agent, a distinction that positions it within the azole drug family, which is clinically recognized for its ability to target systemic fungal infections. This classification reflects its distinct chemical structure and its therapeutic focus on controlling and resolving infections caused by susceptible fungal pathogens. The drug is a single active ingredient product, meaning its therapeutic effect comes solely from Fluconazole.

A unique differentiating factor of Fluconazole compared to some earlier azole antifungals is its high oral bioavailability—meaning the amount absorbed into the bloodstream after taking a tablet is nearly the same as that delivered through an intravenous infusion. This property simplifies the potential transition of care.


Composition and Available Forms

The composition of Flunol centers on the active substance, Fluconazole, prepared for both oral and intravenous administration. It is supplied in various dosage forms, allowing flexibility in patient care: these forms include the oral preparations—Capsule, Tablet, and Oral suspension (a liquid form)—as well as a sterile Intravenous solution for infusion into a vein. The availability of both oral and intravenous options is beneficial because the drug's absorption is similar regardless of the route, ensuring consistent therapeutic levels in the bloodstream.


General Therapeutic Purpose

Fluconazole works by exerting a targeted fungistatic action, which means it primarily inhibits the growth and multiplication of infectious fungal cells. It achieves this by disrupting the production of ergosterol, a crucial structural component of the fungal cell membrane. By preventing the fungus from building and maintaining a stable cell wall, Fluconazole effectively arrests the proliferation of the infectious organism, which in turn helps the body’s immune system gain control over the systemic infection.

Regulatory References

  1. Fluconazole: MedlinePlus Drug Information
Advertisements

What side effects are possible with Flunol (Fluconazole)?

Possible side effects and safety information

The safety profile of Flunol (Fluconazole) is characterized by classifying reported adverse reactions by the body system affected and the frequency of occurrence, as defined in authoritative regulatory documentation.

Frequency-Classified Adverse Reactions

Classification Examples of Affected Body Systems
Very Common Headache (for certain indications)
Common Nausea, Vomiting, Diarrhea, Abdominal Pain, Rash, Liver enzyme increases
Uncommon Anemia, Seizures, Dizziness, Insomnia, Constipation, Jaundice, Fatigue
Rare Agranulocytosis, Anaphylaxis, Hepatic Failure, QT interval prolongation, Torsade de Pointes, Severe dermatological reactions

Serious and Clinically Significant Adverse Reactions

Official regulatory sources identify the potential for serious, life-threatening events. These include Hepatotoxicity (serious liver damage or failure), which may necessitate discontinuation, and severe Hypersensitivity Reactions such as Anaphylaxis. Additionally, rare, severe Dermatological Reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been documented. The drug has been associated with prolongation of the QT interval, a change in the heart's electrical activity that can lead to severe arrhythmias, including Torsade de Pointes.

Population and Exposure-Related Safety Notes

The official safety information includes specific considerations for certain patient groups. Renal impairment requires cautious use and dose adjustment. Chronic, high-dose exposure (400–800 mg/day) during the first trimester of pregnancy is associated with an increased risk of a rare and distinct pattern of congenital anomalies, leading to a change in the product's regulatory pregnancy classification for uses other than a single low dose. The oral suspension form of Flunol is restricted for use in patients with rare hereditary problems such as fructose intolerance.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

The information in this section summarizes documented overdose findings for Fluconazole based on official government regulatory documents.

Documented Overdose Presentations

High-dose exposure or accidental overdose has been officially associated with specific central nervous system manifestations. Reported signs of overdose include hallucinations and paranoid behavior.

Immediate Required Actions

Immediate medical attention must be sought if an overdose of Flunol is suspected or confirmed. Contact a healthcare professional, the nearest emergency department, or a regional Poison Control Centre immediately.

Management procedures defined in regulatory texts are symptomatic and supportive, as no specific antidote is listed for Fluconazole. The following measures are officially documented for managing acute overdose:

  • Supportive Measures: Symptomatic treatment and supportive care should be instituted.
  • Gastric Lavage: This procedure may be employed if clinically indicated to reduce drug absorption.
  • Hemodialysis: Due to Fluconazole’s high water solubility and renal excretion, a three-hour hemodialysis session is documented to significantly decrease the plasma concentration by approximately 50%, making it a primary method for accelerating drug elimination in severe cases.
Advertisements

Therapeutic Uses of Flunol (Fluconazole)

What Flunol (Fluconazole) Treats: Main Uses and Benefits

Fluconazole is commonly used to help with a wide range of fungal infections, providing crucial symptomatic support across several clinical domains.

The therapeutic relevance of this medication spans several key areas, including acute management of vulvovaginal candidiasis (yeast infections), oropharyngeal candidiasis (oral thrush), and esophageal candidiasis. It is also applied in addressing severe conditions like systemic Candida infections (in the bloodstream or organs) and Cryptococcal Meningitis. Furthermore, it supports the management of future symptomatic episodes by providing necessary prophylaxis in certain high-risk patient groups.

The medication is commonly used to help manage distressing symptoms and supports the patient during difficult episodes by easing distress.


Quick Fact: Relief for Symptom Clusters

Symptom Cluster Patient-Oriented Benefit
Burning, Itching, Pain Contributes to improved day-to-day comfort
Dysphagia (Difficulty Swallowing) May assist with maintaining functional stability in the affected area

This support is relevant when symptoms interfere with daily functioning. For deep-seated infections, it is applied in addressing situations with heightened systemic burden, commonly used when short-term symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Flunol (Fluconazole)?

Fluconazole is an antifungal medication commonly prescribed to treat various fungal infections, including vaginal, oral, and systemic candidiasis.

Who Can Use Flunol?

  • Adults and Children: Approved for use in adults and children of various ages, depending on the indication and dosing regimen.
  • Individuals with Fungal Infections: Primarily used to treat infections caused by Candida species and other susceptible fungi.
  • Prophylaxis: Can be used to prevent fungal infections in patients undergoing chemotherapy, radiation, or those with weakened immune systems (e.g., HIV-positive patients or transplant recipients).

Who Cannot Use Flunol (Contraindications)?

Fluconazole is generally contraindicated in individuals with a known hypersensitivity or allergic reaction to fluconazole, other azole antifungals (like ketoconazole or voriconazole), or any components of the formulation.

Co-administration with certain medications is also strictly advised against due to the risk of serious or life-threatening heart rhythm issues. These include but are not limited to:

  • Terfenadine (if using high-dose fluconazole)
  • Cisapride
  • Astemizole
  • Pimozide
  • Quinidine
  • Erythromycin

Individuals with pre-existing liver disease or those taking other medications that can affect liver function may require closer monitoring by their healthcare provider.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Fluconazole (Flunol) is primarily defined by its documented role as a potent inhibitor of hepatic enzymes, specifically CYP2C9 and CYP2C19, and a moderate inhibitor of CYP3A4. This mechanism results in a required regulatory classification of several combinations.


Formally Contraindicated Combinations

Co-administration with specific medicinal products is strictly prohibited in official regulatory labels due to the risk of serious cardiac events stemming from increased plasma concentrations. These substances include Cisapride, Astemizole, Pimozide, Quinidine, and Erythromycin.


Pharmacokinetic and Exposure Alterations

Fluconazole significantly increases the systemic exposure of several co-administered medicines, including Warfarin (leading to increased prothrombin time), Celecoxib (with AUC increasing over 130%), and certain Oral Contraceptives. Conversely, Fluconazole exposure is officially altered by certain agents; for example, Rifampin decreases its exposure, while Hydrochlorothiazide increases it by over 40% due to a reduction in renal clearance.

Official documents state that the absorption of Fluconazole is not clinically impaired by co-administration with food or common antacids.

Advertisements

Mechanism of Action

How Flunol (Fluconazole) Works

Targeted Enzyme Inhibition

Flunol initiates its action through non-competitive inhibition of the fungal enzyme cytochrome P450-dependent 14-alpha demethylase (CYP51). This enzyme is required for sterol synthesis in fungal cells. Flunol binds to the enzyme's heme iron, blocking its catalytic function and preventing the essential C-14 demethylation step from occurring.

Pathway Disruption and Structural Consequence

The inhibition of CYP51 directly compromises the ergosterol biosynthesis pathway. This prevents the conversion of intermediate sterols into ergosterol, the key structural component of the fungal cell membrane. The result is a dual effect: functional ergosterol is depleted, and toxic 14-alpha-methylated sterols accumulate within the cell, leading to severe membrane dysfunction. This mechanistic cascade produces a final physiological consequence on the pathogen: loss of fungal cell membrane integrity, increased permeability, and the eventual cessation of growth or fungal cell death.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Fluconazole is administered through either the oral route (via capsules, tablets, or liquid suspension) or the intravenous (IV) route for systemic distribution. The dosing pattern is structured to achieve effective drug levels rapidly, frequently requiring a Loading Dose on the first day, which is twice the subsequent maintenance dose. Maintenance doses vary significantly based on the treatment course, ranging from a single oral 150 mg administration to a daily regimen of 200 mg to 400 mg.


The standard administration schedule is Once Daily for most maintenance regimens. Oral formulations can be taken independent of food intake as absorption is not affected. Treatment duration is highly variable, ranging from a single day for certain acute conditions to protracted courses extending up to 12 months for specific deep-seated infections.


Special procedural constraints are defined for both routes. The IV solution must be administered at a rate not exceeding 10 mL/minute. For pediatric patients, dosing is based on a mg/kg schedule, and neonates require extended dosing intervals (48 to 72 hours). Furthermore, dose adjustments are mandated for patients with renal impairment to prevent drug accumulation. The daily dosage remains the same when transitioning between oral and intravenous administration, simplifying the overall use protocol.

Advertisements

Recent Clinical Evidence

Research Evidence: Overview of Studies for Flunol (Fluconazole)


Evidence for Use in Vulvovaginal Candidiasis Studies

Research related to vulvovaginal candidiasis (VVC) primarily involves short-term randomized controlled trials (RCTs). These studies were evaluated in research exploring how symptoms change over time, often compared against a placebo or other local antifungal options. Studies measured the evaluation of symptom changes and the measurement of mycological status. The findings describe patterns observed where trials reported measurements of symptom status at short-term follow-up intervals. What remains uncertain is the durability of changes observed in the studies, as long-term effects are not fully established for monitoring future episodic patterns.


Evidence for Use in Mucosal Candidiasis (Oral Thrush and Esophagitis)

Clinical research for candidiasis of the mouth and the esophagus utilized RCTs comparing Fluconazole with other antifungal agents. These studies largely focused on populations with conditions marked by functional limitations, such as those who were immunocompromised. Studies monitored patient-reported outcomes describing perceived discomfort related to functional measures like dysphagia (difficulty swallowing), specifically the status of lesions and functional symptom measurements. Findings indicate patterns in the status of these functional symptoms measured during the study period. Comparative evidence is lacking for the most effective strategies against specific types of non-C. albicans fungal species that have been observed in some study settings.


Evidence for Systemic and Deep-Seated Fungal Infections

Research for serious systemic infections, like Candida in the bloodstream or Cryptococcal Meningitis, was evaluated in large, rigorous RCTs. Studies explored outcomes related to systemic or functional imbalance, with main endpoints measured being overall survival and documented mycological status. The data show patterns related to patient survival measurements across various infection sites. What remains uncertain is the limited data available from high-quality trials for certain high-risk groups, such as those with very low white blood cell counts (neutropenic patients), where comparative studies often include other drug classes. Also, there is limited information for long-term outcomes regarding the healing of specific deep-seated infection sites.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Flunol (Fluconazole) (FAQ)

Q: Is Flunol considered an antibiotic?

Flunol (Fluconazole) is classified as an antifungal medication, not an antibiotic. According to official regulatory documents, its purpose is to treat infections caused by fungi, such as yeast or mold, whereas antibiotics specifically target bacterial infections.


Q: How is Flunol different from clotrimazole or miconazole?

Fluconazole belongs to the triazole class of antifungals and is a systemic medication. Official pharmacological information indicates it is often used when treatment is needed throughout the body because it is predictably absorbed when taken orally, unlike some earlier antifungal agents that are typically used topically (on the skin).


Q: How quickly does Flunol start to work and how long after taking it can I expect to feel better?

Studies and official information indicate that relief from symptoms for common infections like vaginal yeast infections may begin within 24 hours. For more severe or deep-seated fungal infections, the full effect and expected relief may be observed after one to two weeks of therapy.


Q: Is a metallic or altered taste a common side effect of Flunol?

Yes, changes in the way food tastes (sometimes called taste perversion) have been reported as a documented side effect of Flunol (Fluconazole) in regulatory documentation.


Q: Is long-term use of Flunol generally considered safe?

Official warnings state that patients receiving long-term Flunol therapy require close monitoring for potentially serious effects. These effects include liver damage (hepatotoxicity) and the development of alopecia (hair loss), which have been documented in official safety information for extended treatment.


Q: Does Flunol interact with common painkillers like acetaminophen or ibuprofen?

Official drug interaction information indicates that Fluconazole may increase the systemic exposure of certain Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen. No known drug interaction has been identified with acetaminophen.


Q: Can Flunol be taken at the same time as my daily medications?

Official guidance suggests taking the medication at the same time each day. Furthermore, product information indicates that Fluconazole may need to be separated by at least two hours from certain co-administered medications, such as some drugs used for acid reflux (e.g., proton pump inhibitors).


Q: Is Flunol effective against all types of fungal or yeast infections?

While Flunol is effective against many fungal species, regulatory documents note that some species, such as Candida krusei and Candida glabrata, are often inherently resistant or show reduced susceptibility to the drug. This means the medication may not be effective against these specific types of infections.


Q: Why are regular blood tests sometimes needed when taking Flunol?

Regular monitoring is necessary for patients who develop abnormal liver function tests during treatment. This is because official safety information associates the medication with a rare risk of serious liver damage (hepatotoxicity).


Q: Does Flunol target bacterial infections as well?

No, Fluconazole is an antifungal medication and is not effective against infections caused by bacteria. Its mechanism of action is focused on disrupting the structure of fungal cells.


Q: Is it safe to drive or operate machinery after taking Flunol?

Official warnings state that Fluconazole may cause dizziness or seizures in some individuals. Activities requiring mental alertness, such as driving or operating machinery, should be avoided until an individual knows how the medication affects them.


Q: Can Flunol cause hair loss, even temporarily?

Alopecia (hair loss) is a reported side effect in regulatory documents, particularly with long-term therapy. For many patients, the hair loss abated (ceased) after the drug was discontinued.


Q: What are the signs of a severe allergic reaction to Flunol?

Signs of a severe allergic reaction (anaphylaxis) may include shortness of breath, swelling of the face/mouth/throat, hives, or a serious skin rash with peeling or blistering. The regulatory label classifies these reactions as rare but serious.


Q: What does it mean if an infection is 'resistant' to Flunol?

In simple terms, resistance means the medicine will not work against the infection. Official documents define resistance as either the fungus being intrinsically non-susceptible to the drug (microbiological resistance) or the infection failing to clear despite appropriate treatment (clinical resistance).


Q: Does Flunol help treat or prevent Athlete's Foot?

Fluconazole is approved for the treatment of dermatophytosis (a type of fungal infection that includes athlete’s foot) and tinea versicolor in some regulatory jurisdictions.


Q: Can Flunol be used for fungal infections in the nails (onychomycosis)?

Yes, regulatory documentation indicates that Fluconazole is approved for the treatment of fungal infections of the nails (onychomycosis) in some jurisdictions.


Q: Why is Flunol not recommended for people with low potassium levels?

Patients with existing hypokalaemia (low potassium) are noted in official warnings to be at an increased risk of developing serious heart rhythm problems. This includes conditions like QT prolongation and Torsade de Pointes, which are associated with Fluconazole's effect on the heart's electrical activity.


Q: What are the official uses of Flunol approved by government agencies?

Approved uses typically include various forms of Candidiasis (e.g., vaginal, esophageal, oral), Cryptococcal meningitis, and the prevention (prophylaxis) of fungal infections in high-risk patients. The specific approved uses may vary slightly by country.


Q: Can Flunol cause changes in blood sugar levels for people with diabetes?

Official drug interaction information states that Fluconazole can interact with certain oral medications used to treat diabetes (sulfonylureas). This interaction may cause an increase in drug plasma levels that could lead to low blood sugar (hypoglycemia).


Q: If I have a yeast infection, why is Flunol often prescribed instead of a topical cream?

Fluconazole is a systemic antifungal, which means it is absorbed into the bloodstream to treat the infection from within the body. It is often used when systemic treatment is required or preferred over local (topical) therapies due to its reliable oral absorption.


Q: Does Flunol accumulate in skin and nails, and if so, how does this help?

Pharmacological studies cited in regulatory documentation have shown that the concentration of Fluconazole in certain tissues, including the skin, can reach levels up to 10 times the concentration found in the blood plasma. This accumulation contributes to its therapeutic effect in infections affecting these areas.


Q: What are some common herbal supplements or vitamins that may interact with Flunol?

Official regulatory warnings recommend consulting a healthcare professional before taking herbal remedies, vitamins, or supplements as potential interactions have been noted, and these products are not always clinically tested for co-administration safety.


Q: Are there different dosages of Flunol for different types of fungal infections?

Yes, the dosage and duration of Fluconazole treatment vary significantly based on the type and severity of the fungal infection being treated. For example, a single dose is often used for a vaginal yeast infection, while a daily regimen may be prescribed for Cryptococcal meningitis.


Q: Is it true that taking Flunol requires avoiding certain other medications for acid reflux?

Official drug interaction information indicates that Fluconazole is to be separated by at least two hours from certain medications used to treat acid reflux or GERD. These include certain types of drugs known as proton pump inhibitors.


Q: What is the difference between fungistatic and fungicidal action?

Fluconazole is primarily described as fungistatic, meaning it works by inhibiting the growth and multiplication of fungal cells. However, its action may be fungicidal (directly causing the death of the fungal cells) against certain organisms, often in a dose-dependent manner.


Q: Are there any restrictions on activity, like exercise, while taking Flunol?

Official product information lists no specific restrictions on routine physical activities like exercise. However, the regulatory guidance suggests avoiding hazardous tasks (such as driving) if the medication causes central nervous system side effects like dizziness or seizures.


Q: What is a 'loading dose' of Flunol and why is it used?

A loading dose is an initial higher dose (often double the maintenance dose) given on the first day of treatment. Regulatory guidance states this procedure is used to quickly achieve therapeutic concentrations of the drug in the body.


Q: How long after stopping Flunol might drug interactions continue to occur?

The enzyme-inhibiting effect that causes many drug interactions persists in the body for approximately 4 to 5 days after the last dose is taken. This is due to the drug’s pharmacological properties as outlined in official documents.


Q: Is Flunol considered a narrow or broad-spectrum antifungal?

Fluconazole is generally considered to have a broad spectrum of activity compared to many other antifungals. This is because it is effective against a wide range of fungi, including Candida species, Cryptococcus neoformans, and certain types of ringworm (dermatophytes).

Advertisements

How should Flunol (Fluconazole) be stored and disposed of?

Storage and Handling

Fluconazole must be stored according to its specific formulation. Tablets and dry powder for oral suspension must be kept below 30 C (86 F), stored in a tightly closed container, and protected from direct sunlight.

Reconstituted oral suspension requires storage between 5 C and 30 C and must be protected from freezing. Any unused portion of the suspension must be discarded after 14 days.

Injection solutions must also be protected from freezing and should not be used if the liquid appears cloudy, discolored, or contains particles. All forms of Fluconazole must be kept out of the reach of children and often require storage in a locked location.

Disposal

Unused or expired Fluconazole products must be disposed of in accordance with all applicable local and national regulations. Releases to the environment, such as disposing of the medication through wastewater or drains, must be avoided.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flunol (Fluconazole) found in:

A-Z Index: